Johane Boucher-Champagne, executive vice president, early clinical development of PharmaNet Development Group, has been appointed president and chief executive officer of the company’s subsidiary, Anapharm, Inc., effective March 18, 2007. Ms. Boucher-Champagne will report to Mark Di Ianni, the company’s president of early stage operations. “Johane provided valuable assistance during the transition of the early stage business during the past year,” commented Mark Di Ianni. “Her ...